Latest News


Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • November 09, 2018 11:24 AM | Anonymous
    November 9, 2018, Medscape 

    A single oral dose of the investigational antibiotic zoliflodacin performs as well as intramuscular ceftriaxone (Rocephin, Hoffman-LaRoche) for treatment of uncomplicated urogenital and rectal gonococcal infections, a multicenter phase 2 trial suggests. 

    Read more.

  • November 07, 2018 8:41 AM | Anonymous

    November 7, 2018, MedPage Today 

    Women who started taking a statin at the age of 50 or older had a significantly lower risk of developing any histologic type of ovarian cancer over the next decade than non-statin users did, according to a large, case-control study. The study by Daniel Cramer, MD, of Harvard Medical School in Boston, and colleagues also found that the effect was independent of use of any other concomitant medication. 

    Read more.

  • November 05, 2018 8:28 AM | Anonymous
    November 5, 2018, MedPage Today 


    Women who test negative for human papillomavirus (HPV) at or after age 55 can likely forego cervical cancer screening for the rest of their lives, a new modeling study suggests. Although the risk for cervical cancer later in life could be decreased by screening women until age 75, the study model showed that women who test HPV DNA negative to 14 high-risk HPV types and stop screening at 55 have a remaining lifetime cervical cancer risk of less than 1 percent, reported Talia Malagon, PhD, of McGill University in Montreal, and colleagues in Lancet Oncology.  

    Read more.

  • November 05, 2018 8:25 AM | Anonymous

    November  5, 2018, Infectious Disease News  

    Patients with community-onset urinary tract infections caused by Enterobacteriaceae that are resistant to extended-spectrum cephalosporins are less likely to receive initial appropriate antibiotic therapy than those with non-resistant infections and more likely to experience relapse within seven days, according to study results published in Infection Control & Hospital Epidemiology. 

    Read more.

  • November 01, 2018 8:13 AM | Anonymous
    November 1, 2018, AAPA  


    Here's some good news for you — the lowest rates for the only national PA conference start now! Join thousands of PAs in Denver from May 18-22 for CME, networking, social events, and more. Register now to save. Plus, book your hotel room in the official AAPA hotel block and knock another $200 OFF your registration rate. 

    Don't forget - APAOG is planning a member meeting at AAPA 2019! Watch for more details on when and where to join us! 

    Register today and save!

  • October 31, 2018 7:57 AM | Anonymous

    October 31, 2018, News Medical  

    Ultrasound is one of the three main technologies used in medical imaging. It is more compact and affordable than nuclear magnetic resonance imaging (MRI) techniques, and safer than X-rays. But the images it produces are often difficult to interpret. A research team has developed a new method based on the speed of sound. 

    Read more.

  • October 26, 2018 11:20 AM | Anonymous

    October 26, 2018, Cancer Research UK via Medical Xpress  

    A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new clinical trial results. The study, published in the New England Journal of Medicine, found that the drug olaparib (Lynparza) could delay the return of advanced ovarian cancer in some woman whose cancer cells carry a faulty BRCA gene, or stopped the disease from getting worse.

    Read more.

  • October 25, 2018 1:25 PM | Anonymous

    October 25, 2018, Cure Today 

    The anti-PD-1 monoclonal antibody TSR-042 appeared to be safe and effective in the treatment of patients with microsatellite-high (MSI-H) endometrial cancer, according to preliminary results presented at the European Society for Medical Oncology (ESMO)'s 2018 Congress.  

    Read more.

  • October 25, 2018 1:22 PM | Anonymous

    October 25, 2018, Medscape  

    The so-called liquid biopsy holds great promise for detecting a variety of cancers more accurately, guiding individualized therapy, and improving monitoring during treatment. New data suggest that testing for plasma circulating tumor human papillomavirus DNA (ctHPVDNA) can be an effective method of surveillance for patients with p16-positive oropharyngeal squamous cell carcinoma (OPSCC). c

    Read more.

  • October 23, 2018 10:37 AM | Anonymous

    October 22, 2018, European Society for Medical Oncology via Medical Xpress  

    Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced breast cancer with the alpha-specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib significantly improves progression-free survival, according to late-breaking results reported at ESMO 2018.  

    Read more.

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
Powered by Wild Apricot Membership Software